The FDA has announced its approval of the antibacterial agent levofloxacin, or “Levaquin,” to treat and prevent the plague. Manufactured by Johnson & Johnson, Levaquin was approved under the FDA’s Animal Efficacy rule which allows results from animal testing to be studied if such tests on humans aren’t ethical or feasible.

The FAIR Foundation’s CEO, Dr.

In the past decade, scientists have made significant progress building the critical knowledge and infrastructure needed to identify and develop novel tuberculosis (TB) vaccine candidates and move the most promising ones into human clinical trials.

Unpredictable, ever-changing and with potentially far-reaching effects on the fates of nations, infectious diseases are compelling actors in the drama of human history.

An experimental vaccine tested in rhesus monkeys helped protect them from getting infected with Simian Immunodeficiency Virus (SIV) -- the primate version of HIV and AIDS -- and appears to make the disease more manageable in those who aren’t protected.